HIGHLIGHTS
- who: Hiroshige Mikamo and colleagues from the Aichi Medical University, Nagakute, Aichi, Japan, Medical University have published the research work: Comparing the cobas Influenza A/B Nucleic acid test for use on the cobas Liat System (Liat) with rapid antigen tests for clinical management of Japanese patients at the point of care, in the Journal: PLOS ONE of 16/03/2021
- what: This study was to assess the clinical performance of molecular POC testing using the Liat test versus the standard of care testing using RADTs in patients presenting with ILI during flu season in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.